The results also revealed the regulatory mechanism by which CEL affects RA‐FLS and macrophages, and confirmed the regulatory significance of the IGF2BP3/RASGRF1/mTORC1 axis in CEL‐mediated reductions in cell proliferation and inflammatory activation. The gene discussed is RASGRF1; the disease is rheumatoid arthritis.